KARENTON MORDI: Open Payments
NPI 1831675636 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 7 companies in 2025. Trend: 2023 $94 · 2024 $146 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| Almatica Pharma LLC | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: COBENFY, LOREEV XR, REXULTI, CAPLYTA, INGREZZA, FANAPT, Qelbree.
Industry payments across PA — which companies pay providers there.
